New findings from IGP show an alternative way to administer the therapy, which has the same effect on the tumour but less impact other parts of the body | ScienceDaily
Image shows photomicrograph (magnification X60) of botyroidal rhabdomyoscarcoma of the bladder
In the study immune activation was achieved by administering blocking antibodies close to the tumour. The results complement the researcher’s previous findings where they found that a direct immune stimulatory antibody had superior anti-tumour capacity when used locally at the tumour, as compared to after injection into the blood.
The hope is also that the immune cells, not the drug itself, can find potential metastases and eliminate them. To understand if and how this is happening, further research is required. The present results are based on studies in mice and to determine if drug administration to the tumour results in fewer adverse events in patients, as compared to injections into the blood stream, clinical studies are also needed.
Read the full overview here
Read the original research abstract here